The Data Space developed by Telefónica Tech for Evidenze has been created with the aim of facilitating the secure, sovereign, and efficient exchange of data between organisations in the healthcare sector, thereby promoting collaboration and the advanced use of clinical information.

The solution includes two use cases based on data collected during a phase I-II randomised, open-label, multicentre, national clinical trial conducted to assess the efficacy and security of treatment for patients with untreated metastatic pancreatic cancer.

The first use case employs artificial intelligence models to predict potential adverse effects associated with the administered drugs, facilitating preventive clinical decisions and potential adjustments to medication. The second analyses sociodemographic, analytical, clinical, and therapeutic variables to identify patterns related to treatment effectiveness and patient survival.